The -323/-314 sequence located in the GSTP1 promoter binds to NF-Bp50/65 and p65/p65 dimers, and is involved in the regulation of this gene by tumor necrosis factor (36-38)
Chen, X., Zhao, P., Wang, W., Guo, L
These trials led to FDA approval Male ED Phase 2 double-blind, placebo-controlled studies in men demonstrated that PT-141 improved erectile response measured by RigiScan, with efficacy in a subset of men who had not responded to sildenafil Functional neuroimaging fMRI studies confirmed that PT-141 activates brain regions associated with sexual arousal, providing direct evidence of its central mechanism Dose-response clinical studies established the 1.75 mg subcutaneous dose as the optimal balance of efficacy and tolerability Evidence Gap# The evidence profiles differ both in depth and in indication
Metabolic research focus: Studied in obese rodent models for effects on fat oxidation, weight gain trends, and markers linked to fat breakdown and storage
Abstract Alcohol use disorder (AUD) and binge drinking are highly prevalent public health issues